Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Borges

Showing results (411-420 of 454) with videos related to

Pageof 46
Sort By:
Journal of the American College of Radiology : JACR|November 5, 2025
ACR Appropriateness Criteria® Breast Imaging During Pregnancy, Lonie R Salkowski, Alana A Lewin, et al.
Annals of Surgery|December 30, 2020
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort StudyHee Jeong Kim, Laura Dominici, Shoshana M Rosenberg, et al.
British Journal of Cancer|October 27, 2021
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancerYaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot studyHarold J Burstein, Lyndsay N Harris, Rebecca Gelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2022
Somatic and Germline Genomic Alterations in Very Young Women with Breast CancerAdrienne G Waks, Dewey Kim, Esha Jain, et al.
JCO Precision Oncology|June 26, 2023
Genomics of <i>ERBB2</i>-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2017
Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER ConsortiumLynn Chollet-Hinton, Andrew F Olshan, Hazel B Nichols, et al.
Journal of the National Cancer Institute|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancerGuilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
British Journal of Pharmacology|November 22, 2023
Paediatric sepsis survivors are resistant to sepsis-induced long-term immune dysfunctionDavid F Colón, Carlos W Wanderley, Walter M Turato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2019
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, et al.
Pageof 46

Showing results (411-420 of 454) with videos related to

Sort By:
Pageof 46
Journal of the American College of Radiology : JACR|November 5, 2025
ACR Appropriateness Criteria® Breast Imaging During Pregnancy, Lonie R Salkowski, Alana A Lewin, et al.
Annals of Surgery|December 30, 2020
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort StudyHee Jeong Kim, Laura Dominici, Shoshana M Rosenberg, et al.
British Journal of Cancer|October 27, 2021
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancerYaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot studyHarold J Burstein, Lyndsay N Harris, Rebecca Gelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2022
Somatic and Germline Genomic Alterations in Very Young Women with Breast CancerAdrienne G Waks, Dewey Kim, Esha Jain, et al.
JCO Precision Oncology|June 26, 2023
Genomics of <i>ERBB2</i>-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2017
Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER ConsortiumLynn Chollet-Hinton, Andrew F Olshan, Hazel B Nichols, et al.
Journal of the National Cancer Institute|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancerGuilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
British Journal of Pharmacology|November 22, 2023
Paediatric sepsis survivors are resistant to sepsis-induced long-term immune dysfunctionDavid F Colón, Carlos W Wanderley, Walter M Turato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2019
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, et al.
Pageof 46